KARADANOTE INC. (JP:4014)
:4014
Top Page
KARADANOTE INC.
(4014)
Select Model
Select Model
Rating:45Neutral
Price Target:
¥398.00
▼(-17.08% Downside)
Action:ReiteratedDate:03/24/26
The score is held down primarily by weak financial performance—especially sustained negative operating and free cash flow and the latest-year return to losses alongside revenue decline. Technicals add pressure as the stock trades below major moving averages with negative MACD. Valuation is a partial offset with a moderate P/E, but lacks dividend-yield support.
Positive Factors
Niche digital health parenting platform
A focused product set serving expectant parents, families and health-conscious users supports durable product-market fit. These life-stage services tend to generate steady, repeat usage and high engagement, which underpins long-term retention and recurring monetization opportunities.
Negative Factors
Negative cash generation
Sustained negative operating and free cash flow means the core business is not self-funding growth or operations. Persistent cash outflows increase reliance on external financing, raise execution risk for product investments, and limit the firm's ability to absorb shocks over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Niche digital health parenting platform
A focused product set serving expectant parents, families and health-conscious users supports durable product-market fit. These life-stage services tend to generate steady, repeat usage and high engagement, which underpins long-term retention and recurring monetization opportunities.
Read all positive factors
KARADANOTE INC. (4014) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥2.76B
Dividend YieldN/A
Average Volume (3M)13.65K
Price to Earnings (P/E)13.8
Beta (1Y)0.87
Revenue Growth-51.54%
EPS Growth-111.68%
CountryJP
Employees45
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)8.14
Shares Outstanding6,697,900
10 Day Avg. Volume6,780
30 Day Avg. Volume13,653
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)6.40
Price to Sales (P/S)2.42
P/FCF Ratio-26.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
KARADANOTE INC. Business Overview & Revenue Model
Company Description
Karadanote Inc. plans and develops applications related to pregnancy, childbirth, and childcare for medication and health management. It also provides media planning and management services; and insurance agency services. The company was incorpora...
KARADANOTE INC. Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
56
Neutral
Cash Flow
24
Negative
| Breakdown | Jul 2025 | Jul 2024 | Jul 2023 | Jul 2022 | Jul 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.27B | 2.19B | 2.06B | 1.31B | 1.00B |
| Gross Profit | 619.00M | 1.48B | 1.52B | 916.51M | 760.43M |
| EBITDA | -51.91M | 102.11M | -370.80M | -312.56M | 214.28M |
| Net Income | -69.00M | 114.89M | -372.46M | -271.73M | 139.05M |
Balance Sheet | |||||
| Total Assets | 768.60M | 1.23B | 1.09B | 1.48B | 1.14B |
| Cash, Cash Equivalents and Short-Term Investments | 596.08M | 483.48M | 686.65M | 1.04B | 964.94M |
| Total Debt | 200.00M | 300.00M | 400.00M | 500.00M | 0.00 |
| Total Liabilities | 288.14M | 875.75M | 866.14M | 906.04M | 170.99M |
| Stockholders Equity | 480.45M | 352.65M | 221.58M | 573.81M | 967.85M |
Cash Flow | |||||
| Free Cash Flow | -116.00M | -110.37M | -258.22M | -349.08M | 163.79M |
| Operating Cash Flow | -115.00M | -107.37M | -255.41M | -346.91M | 185.22M |
| Investing Cash Flow | 143.00M | -3.00M | -2.81M | -3.79M | -32.34M |
| Financing Cash Flow | 84.63M | -92.80M | -93.45M | 424.09M | 497.06M |
KARADANOTE INC. Technical Analysis
Negative
480.00
Price Trends
437.62
Negative
448.59
Negative
467.94
Negative
Market Momentum
-7.78
Negative
43.99
Neutral
61.65
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4014, the sentiment is Negative. The current price of 480 is above the 20-day moving average (MA) of 421.40, above the 50-day MA of 437.62, and above the 200-day MA of 467.94, indicating a bearish trend. The MACD of -7.78 indicates Negative momentum. The RSI at 43.99 is Neutral, neither overbought nor oversold. The STOCH value of 61.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4014.
KARADANOTE INC. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥32.09B | 36.54 | ― | 0.47% | 31.05% | 46.12% | |
66 Neutral | ¥4.83B | 21.99 | ― | ― | 7.60% | 19.13% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥7.00B | 27.15 | ― | ― | 11.32% | ― | |
59 Neutral | ¥8.99B | 60.24 | ― | 0.12% | 37.21% | 129.72% | |
56 Neutral | ¥5.59B | -26.75 | ― | ― | -3.20% | -39.38% | |
45 Neutral | ¥2.76B | 13.84 | ― | ― | -51.54% | -111.68% |
* Technology Sector Average
JP:4014
KARADANOTE INC.
412.00
18.00
4.57%
JP:4074
LaKeel,Inc
729.00
-101.00
-12.17%
JP:4397
TeamSpirit, Inc.
424.00
28.00
7.07%
JP:5033
Nulab Inc.
745.00
-191.00
-20.41%
JP:5038
eWeLL Co.,Ltd
2,104.00
119.20
6.01%
JP:5588
Fast Accounting Co.,Ltd.
800.00
-636.75
-44.32%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.